Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients (Q41829254)
Jump to navigation
Jump to search
scientific article published on 19 January 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients |
scientific article published on 19 January 2017 |
Statements
1 reference
Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients (English)
1 reference
0 references
Shu Su
1 reference
Bian Hu
1 reference
Jie Shao
1 reference
Bin Shen
1 reference
Juan Du
1 reference
Yinan Du
1 reference
Jiankui Zhou
1 reference
Lixia Yu
1 reference
Lianru Zhang
1 reference
Fangjun Chen
1 reference
Huizi Sha
1 reference
Lei Cheng
1 reference
Fanyan Meng
1 reference
Zhengyun Zou
1 reference
Xingxu Huang
1 reference
Baorui Liu
1 reference
19 January 2017
1 reference
1 reference
40272
1 reference
19 January 2017
1 reference
Identifiers
1 reference
1 reference
1 reference